eCM (Eur Cell Mater / e Cells & Materials) eCM Open Access Scientific Journal
 ISSN:1473-2262         NLM:100973416 (link)         DOI:10.22203/eCM

2025   Volume No 51 – pages 145-157

Title: Enhancing human osteoblast to osteocyte-like cell differentiation using 25-hydroxyvitamin D3 and all-trans retinoic acid combination

Authors: A Munir, AE Agger, A Samara, JE Reseland, LB Solberg

Address: Division of Orthopaedic Surgery, Oslo University Hospital, N-0424 Oslo, Norway

E-mail: l.b.solberg at gmail.com

Abstract: Background: The individual effects of the 25-hydroxyvitamin D3 (25(OH)D3) and all-trans retinoic acid (ATRA) on osteogenesis have been studied in two-dimensional (2D) in vitro models, but the combined effect of these vitamins remains largely unexplored. Therefore, to address this knowledge gap we evaluated the effect of different concentrations of 25(OH)D3 and ATRA, individually and in combination, on differentiation of primary human osteoblasts (hOBs) over a 21-day period. Methods: The growth of hOBs, alkaline phosphatase (ALP) activity (cell bound and secreted), and the expression of bone-related markers were comprehensively evaluated at both gene expression level using real-time polymerase chain reaction (RT-PCR) and the proteins secretion through multiplex immunoassays. Results: Both 25(OH)D3 and ATRA enhanced hOBs differentiation. However, the combination of 10−6 M 25(OH)D3 and 10−5 M ATRA demonstrated the most pronounced effect, characterized by reduction in cell growth and enhancement in differentiation. This was further validated by elevated relative expression of osteoblast and osteocyte markers at both mRNA level (collagen type I alpha 1 (COL1A1), podoplanin (E11), and dentin matrix acidic phosphoprotein 1 (DMP1), and at protein level (osteopontin (OPN), osteocalcin (OCN), sclerostin (SOST), and fibroblast growth factor 23 (FGF23)). Additionally, 25(OH)D3 and ATRA were found to regulate the expression of key receptors involved in osteoblasts differentiation, including retinoic acid receptor alpha (RARα), retinoid X receptor beta (RXRβ), and vitamin D receptor (VDR). Conclusions: This study demonstrates that a combination of 10−6 M 25(OH)D3 and 10−5 M ATRA effectively enhanced the differentiation of hOBs to osteocyte-like cells in vitro.

Keywords: Osteocytes, osteoblasts, atra, 25(OH)D3, in vitro.

Publication date: 26th June 2025

Copyright policy: © 2025 The Author(s). Published by Forum Multimedia Publishing, LLC. This article is distributed in accordance with Creative Commons Attribution Licence (http://creativecommons.org/licenses/by/4.0/).

Article download: Pages 145-157 (PDF file)
DOI:
10.22203/eCM.v051a09

Supplementary material

Twitter Facebook Google LinkedIn Print